I
Oct 23, 2026IPO Buzz: Akums Drugs' Successful Listing and Its Significance for Pharma IPOs
Akums Drugs' IPO debut with a 6.7% premium signals strong investor interest in pharma, reflecting broader sector trends.
Oct 23, 20263 min read0 reactions0 comments